Your browser doesn't support javascript.
loading
Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelines.
Simpson, Bryan H; Reith, David M; Medlicott, Natalie J; Smith, Alesha J.
Affiliation
  • Simpson BH; School of Pharmacy, University of Otago, Dunedin, New Zealand; and Corresponding author. Email: bryan.simpson@postgrad.otago.ac.nz.
  • Reith DM; Otago Medical School, University of Otago, Dunedin, New Zealand.
  • Medlicott NJ; School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • Smith AJ; School of Pharmacy, University of Otago, Dunedin, New Zealand.
J Prim Health Care ; 12(4): 327-334, 2020 12.
Article in En | MEDLINE | ID: mdl-33349320
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antithrombins / Drug Monitoring / Creatinine / Stroke / Dabigatran Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antithrombins / Drug Monitoring / Creatinine / Stroke / Dabigatran Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Year: 2020 Type: Article